Clinical Trial Update: Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism? [EARLY_Phase 1]

View source ↗

Summary

This ClinicalTrials.gov entry describes an early-phase 1 study investigating whether spironolactone can normalize sleep-wake luteinizing hormone pulse frequency…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperandrogenism
• Polycystic Ovary Syndrome

Drugs mentioned

• Aldactone (spironolactone)

Snippet

Sponsor: University of Virginia | Conditions: Hyperandrogenism, Polycystic Ovary Syndrome | EARLY_Phase 1 | Status: RECRUITING